American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

NORTHWEST BIOTHERAPEUTICS INC (NWBO)

$0.15 +0.46% OTC: NWBO · 15-min delayed

BETHESDA, Maryland
Public · OTC: NWBO

Visit website Follow

$1.4MRevenue · FY2025

-$60.2MNet income

NWBOOTC

About NORTHWEST BIOTHERAPEUTICS INC

NORTHWEST BIOTHRPUTCS INC

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · OTC: NWBO
Headquarters: BETHESDA, Maryland
Industry: Pharmaceuticals
Website: Visit site

Incorporation record

Incorporated in: DE, United States
Registered office: Wilmington, US
Legal entity ID: 5493002DRWWEOWTT8005

Source: GLEIF, the global Legal Entity Identifier registry · checked Jul 26, 2026. A US headquarters does not always mean US incorporation.

Registry IDs

Ticker: NWBO OTC
SEC CIK: 1072379
LEI: 5493002DRWWEOWTT8005
EIN: 943306718
SIC: 2834 Pharmaceutical Preparations

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show Northwest Biotherapeutics Inc’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/northwest-biotherapeutics-inc/"><img src="https://americancompanies.com/badge/northwest-biotherapeutics-inc.svg" alt="Northwest Biotherapeutics Inc — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow NORTHWEST BIOTHERAPEUTICS INC and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

Reported figures

Financial summary

Revenue FY2025: $1.4M
Net income: -$60.2M
Total assets: $81.3M

Source: SEC EDGAR · updated Jun 7, 2026

OTC: NWBO

$0.15 +0.46%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$0.15 $0.32

52-week range

Open: —
Day range: –
Prev close: —
Volume: —

Northwest Biotherapeutics Inc (NWBO) Stock Price

Reported a net loss of $60.2M in FY2025.
Trading 53% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review NORTHWEST BIOTHERAPEUTICS INC.

Write a review

Newsroom

News about NORTHWEST BIOTHERAPEUTICS INC

Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform Benzinga · 2026-04-30 · positive Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic Benzinga · 2026-04-21 · positive Northwest Biotherapeutics Announces That Its Acquisition of Advent BioServices Ltd. Has Closed Benzinga · 2025-10-24 · positive Northwest Biotherapeutics Announces Agreement to Acquire Advent BioServices Ltd. Benzinga · 2025-08-27 · positive

News & sentiment via Polygon.io

FAQ

Northwest Biotherapeutics Inc: frequently asked questions

Is Northwest Biotherapeutics Inc an American company?

Northwest Biotherapeutics Inc is a US-based company headquartered in Bethesda, Maryland, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is Northwest Biotherapeutics Inc headquartered?

Northwest Biotherapeutics Inc is headquartered in Bethesda, Maryland, United States.

Is Northwest Biotherapeutics Inc publicly traded?

Yes — Northwest Biotherapeutics Inc is a publicly traded company. Its stock trades under the ticker symbol NWBO on the OTC.

What does Northwest Biotherapeutics Inc do?

Northwest Biotherapeutics Inc is an American Pharmaceuticals company in the Health & Beauty sector.

Explore